Your browser doesn't support javascript.
loading
COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
Lee, Lennard Yw; Cazier, Jean-Baptiste; Angelis, Vasileios; Arnold, Roland; Bisht, Vartika; Campton, Naomi A; Chackathayil, Julia; Cheng, Vinton Wt; Curley, Helen M; Fittall, Matthew W; Freeman-Mills, Luke; Gennatas, Spyridon; Goel, Anshita; Hartley, Simon; Hughes, Daniel J; Kerr, David; Lee, Alvin Jx; Lee, Rebecca J; McGrath, Sophie E; Middleton, Christopher P; Murugaesu, Nirupa; Newsom-Davis, Thomas; Okines, Alicia Fc; Olsson-Brown, Anna C; Palles, Claire; Pan, Yi; Pettengell, Ruth; Powles, Thomas; Protheroe, Emily A; Purshouse, Karin; Sharma-Oates, Archana; Sivakumar, Shivan; Smith, Ashley J; Starkey, Thomas; Turnbull, Chris D; Várnai, Csilla; Yousaf, Nadia; Kerr, Rachel; Middleton, Gary.
  • Lee LY; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK. Electronic address: l.lee.2@bham.ac.uk.
  • Cazier JB; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK.
  • Angelis V; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Arnold R; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Bisht V; Centre for Computational Biology, University of Birmingham, Birmingham, UK; University of Birmingham, Birmingham, UK.
  • Campton NA; Institute of Translational Medicine, Birmingham Health Partners, Birmingham, UK.
  • Chackathayil J; Cancer Research Clinical Research Facility, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Cheng VW; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Curley HM; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Fittall MW; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Freeman-Mills L; Glasgow Royal Infirmary, Glasgow, UK.
  • Gennatas S; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Goel A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Hartley S; Centre for Computational Biology, University of Birmingham, Birmingham, UK; Advanced Research Computing, University of Birmingham, Birmingham, UK.
  • Hughes DJ; Department of Cancer Imaging, King's College London, London, UK.
  • Kerr D; Nuffield Division of Clinical and Laboratory Services, Oxford University, Oxford, UK.
  • Lee AJ; UCL Cancer Institute, University College London, London, UK.
  • Lee RJ; University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.
  • McGrath SE; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Middleton CP; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK.
  • Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK.
  • Newsom-Davis T; Department of Oncology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
  • Okines AF; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Olsson-Brown AC; The Clatterbridge Cancer Centre, Wirral, UK.
  • Palles C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Pan Y; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK.
  • Pettengell R; St George's University of London, London, UK.
  • Powles T; Bart's Cancer Institute, London, UK.
  • Protheroe EA; University of Birmingham Medical School, University of Birmingham, Birmingham, UK.
  • Purshouse K; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
  • Sharma-Oates A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Sivakumar S; Department of Oncology, Oxford University, Oxford, UK.
  • Smith AJ; Consultancy Support, Oxford, UK.
  • Starkey T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Turnbull CD; Nuffield Department of Medicine, Oxford University, Oxford, UK.
  • Várnai C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Centre for Computational Biology, University of Birmingham, Birmingham, UK.
  • Yousaf N; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Kerr R; Department of Oncology, Oxford University, Oxford, UK.
  • Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK; University Hospitals Birmingham, Birmingham, UK.
Lancet ; 395(10241): 1919-1926, 2020 06 20.
Article en En | MEDLINE | ID: mdl-32473682
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Neoplasias / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Neoplasias / Antineoplásicos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article